The Global Prefilled Syringes Drug Molecules market is expected to exceed more than US$ 76 Billion by 2028 at a CAGR of 5.7% in the given forecast period.
Prefilled syringes provide inexpensive home setting medication and reduce time consumed at in-patient and out-patient care units. Prefilled syringes drug delivery is convenient for patients who need parenteral administration of drugs on a daily or weekly basis and long term treatment. It makes them prefer more of self-administrated devices where patients don’t have to stay dependent on doctors for every dosage and also reduces the average cost per injection, when compared to vials and ampoules. There is also a decrease in the reliance on health care professionals in many regions, and this is also likely to boost global market revenue growth.
Prefilled syringes drug delivery is preferred over conventional vials, as it facilitates various benefits such as less over-filling as well as safe and convenient use, thus increasing the demand for prefilled syringes drug molecules.
The global Prefilled Syringes Drug Molecules market is segregated on the basis of Application as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores. Based on Type the global Prefilled Syringes Drug Molecules market is segmented in Vaccines, Insulin, Adrenaline, Opioids, and Others.
The global Prefilled Syringes Drug Molecules market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Prefilled Syringes Drug Molecules market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Pfizer, Inc., Fresenius Kabi AG, Johnson & Johnson, Sanofi, Merck & Co. Inc., Novartis AG, and others are among the major players in the global Prefilled Syringes Drug Molecules market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Prefilled Syringes Drug Molecules Market has been segmented as below:
Prefilled Syringes Drug Molecules Market, By Application
Prefilled Syringes Drug Molecules Market, By Type
Prefilled Syringes Drug Molecules Market, By Region
Prefilled Syringes Drug Molecules Market, By Company
The report covers:
Report Scope:
The global Prefilled Syringes Drug Molecules market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Prefilled Syringes Drug Molecules market share. Major industry players with significant revenue share include Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Pfizer, Inc., Fresenius Kabi AG, Johnson & Johnson, Sanofi, Merck & Co. Inc., Novartis AG, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Insulin Delivery Devices Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Prefilled Syringes Drug Molecules Market, By Application
5.1 Introduction
5.2 Hospital Pharmacies
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Retail Pharmacies
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Online Pharmacies
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Drug Stores
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Prefilled Syringes Drug Molecules Market, By Type
6.1 Introduction
6.2 Vaccines
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Insulin
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Adrenaline
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Opioids
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Others
6.6.1 Market Overview
6.6.2 Market Size and Forecast
7. Prefilled Syringes Drug Molecules Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Prefilled Syringes Drug Molecules, By Application
7.2.2 North America Prefilled Syringes Drug Molecules, By Type
7.3 Europe
7.3.1 Europe Prefilled Syringes Drug Molecules, By Application
7.3.2 Europe Prefilled Syringes Drug Molecules, By Type
7.4 Asia-Pacific
7.4.1 Asia-Pacific Prefilled Syringes Drug Molecules, By Application
7.4.2 Asia-Pacific Prefilled Syringes Drug Molecules, By Type
7.5 Rest of the World
7.5.1 Rest of the World Prefilled Syringes Drug Molecules, By Application
7.5.2 Rest of the World Prefilled Syringes Drug Molecules, By Type
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Amgen Inc.
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Teva Pharmaceutical Industries Ltd.
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 AstraZeneca plc
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Mylan N.V.
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Pfizer, Inc.
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Fresenius Kabi AG
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Johnson & Johnson
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Sanofi
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Merck & Co. Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Novartis AG
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Prefilled Syringes Drug Molecules Market has been segmented as below:
Prefilled Syringes Drug Molecules Market, By Application
Prefilled Syringes Drug Molecules Market, By Type
Prefilled Syringes Drug Molecules Market, By Region
Prefilled Syringes Drug Molecules Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
